MEDISCA, a global compounding solutions provider, has said it will host the first-ever World Congress of Compounding on October 27-28, 2018 in Las Vegas, US.
As an international industry conference, the World Congress of Compounding will bring together top-level speakers, key health leaders, and decision makers.
The event will present new business solutions and present opportunities for healthcare professionals around the world. Each session will promote comprehensive coverage of significant therapeutic plan research topics including Hormone Restoration Therapy, Pain Management, Veterinary Medicine and regulatory updates.
“Through the World Congress of Compounding, MEDISCA is striving to create a conducive environment to exchange ideas, generate innovative solutions that improve the lives of patients, and promote growth within the personalised medicine industry,” said Antonio Dos Santos, president of MEDISCA. He added: “We are matching expertise with passion in a way that hasn’t been done before.”
Daniel Kraft, MD, founder and chair of Exponential Medicine, a programme which studies the potential of new technologies in biomedicine and healthcare, will serve as the keynote speaker.
With over 25 years of experience in clinical practice, biomedical research, and healthcare innovation, Kraft will explore the impact of rapidly developing technologies on the way we address major medical care challenges such as the aging population, the fragmentation of care, and the variation in clinical practice.
Additional featured speakers include:
- Aaron Lopez, political consultant, Political Capital
- Christine Roussel, assistant director of pharmacy at Doylestown Hospital
- Franziska Scharpf, owner of the compounding pharmacy Apotheke Scharpf in Sonthofen, Germany
- Jeffery A. Johnson, pharmacist and 30-year veteran of the US Armed Forces
- Quinton Didyk, pharmacist, owner of The Compounding Pharmacy of Manitoba
- Vanessa Pinheiro, consultant for MEDISCA Network’s Technical Support Services Department
- Vassilios Papadopoulos, dean of USC School of Pharmacy
- Zahra Mehdizadeh Kashi, founder and CEO of Kashi Clinical Laboratories
The conference is sponsored by MEDISCA and its global partners, MEDISCA Network and LP3 Network, and will feature renowned speakers from across the personalized healthcare industry.
